Accelerate Your Data with Our Co-located Clinic and Lab

Ensuring Chain of Custody from Clinic to Lab

Did you know that our Canadian clinical facility is only a 15-minute drive from our bioanalytical facility?

This two-minute video provides an overview of our workflows, optimized to ensure timely collection, processing, transport, and rapid analysis of your samples for expedited go/no-go decision-making. Altasciences’ highly trained clinical staff and lab analysts understand the time-sensitive nature of your projects. Real-time access to essential data is our top priority.

Watch Now

Speak with one of our experts to learn more about our solution and how we can support your program.

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services.

Have five minutes? Take a look at these:

Scratching the Surface of Dermal Testing

Avoid These Mistakes During Formulation for Nonclinical Testing

Improve Your Odds of Success

Formulation development is a critical step that ensures the drug product is produced safely and effectively for use in nonclinical testing and, eventually, in clinical trials. Solubility, stability, route of administration, and dosage frequency are some of the factors assessed during formulation development.

In this podcast, our scientific experts discuss the everyday challenges encountered in formulation development for nonclinical testing, and tips to avoid or mitigate them to facilitate your IND application.



Do you need your API formulated and manufactured for nonclinical testing? Contact us today to get started!

Related Resources:

  • Webpage: Contract Manufacturing and Analytical Solutions
  • Interview: Complex and Customized Formulation Development
  • Podcast: Key Considerations as You Move From Discovery to Preclinical to Clinical

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

.custom-column-left-text { float: left; width: 50%; padding-right: 10px; } .custom-column-right-text { float: right; width: 45%; text-align:center; } @media only screen and (max-width: 600px) { .custom-column-left-text, .custom-column-right-text, .custom-column-flc-ebook-text { float:none; width:80%; margin:0 auto; } }

Opinion | A Day to Celebrate, and a Call to Action

Dr.

Case Study―Evaluating Milling Conditions for Scaling Up a Nanosuspension Drug Product

Benefits of Increasing Automation in the Lab

In this webinar, learn about the extent of automation within bioanalysis in today’s landscape, the practicality of automated technologies for extraction methods and ligand binding assays, and future projections for bioanalytical automation.

 

Speak with an expert about your research needs.

You may also be interested in the following:

A Leading Partner in Ophthalmic Drug Development

Comprehensive Ophthalmic Drug Development Solutions

As an industry leader in ophthalmic drug development and research, our integrated CRO/CDMO solutions allow you to work with a single partner as your ocular compound advances from prototype formulation to preclinical testing through to early phase clinical trials and manufacturing.

Discover how Altasciences' end-to-end ophthalmic drug development solutions can help reduce your timelines by up to 40%!

Have questions? Consult with one of our experts.

You may also be interested in:

Best Practices for a Successful, Multi-Step Data Journey

In this latest issue of The Altascientist, we guide you through the complex, multi-step data journey for Phase I clinical trials, from study conceptualization and protocol development, to data collection and analysis, through to final regulatory submission. We highlight best practices and approaches to mitigate challenges, and show how integration and collaboration build the strongest datasets for your drug development program.

Speak with an expert to learn more about our service offering.

Have a few more minutes? Check out these insightful resources:

Subscribe to